Anti-oxidant Effects of Resveratrol on Mice with DSS-induced Ulcerative Colitis

Archives of Medical Research

Volumn 41, Issue 4, 2010, Pages 288-294

  Yao, Jun ^a   Wang, Jian Yao ^a   Liu, Lei ^a   Li, Ying Xue ^a   Xun, An Ying ^b   Zeng, Wei Sen ^c   Jia, Chun Hong ^c   Wei, Xiao Xia ^a   Feng, Ju Ling ^a   Zhao, Li ^c   Wang, Li Sheng ^a  

^a JINAN UNIVERSITY   (China)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Oxidative damage; Resveratrol; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; GLYCOPROTEIN GP 91; INTERLEUKIN 8; MALONALDEHYDE; MYELOPEROXIDASE; PROTEIN P22; RESVERATROL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; GLUTATHIONE PEROXIDASE; PEROXIDASE; PRIMER DNA; REACTIVE OXYGEN METABOLITE; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COLON; COLORIMETRY; CONTROL GROUP; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; ENZYMOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; TOXICITY;

ANIMALS; ANTIOXIDANTS; BASE SEQUENCE; BLOTTING, WESTERN; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE PEROXIDASE; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; PEROXIDASE; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES;

EID: 77954651225     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.05.002     Document Type: Article

References (42)

1. Araki Y., Andoh A., Fujiyama Y. The free radical scavenger edaravone suppresses experimental dextran sulphate sodiuminduced colitis in rats. Int J Mol Med 2003, 12:125-129.
2. Bitirem M., Karakilcik A.Z., Zerin M., et al. Protective effects of selenium and vitamin E combination on experimental colitis in blood plasma and colon of rats. Biol Trace Elem Res 2009, 23. [Epub ahead of print].
3. Sartor R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology 2004, 126:1620-1633.
4. De Hertogh G., Aerssens J., Geboes K.P., et al. Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol 2008, 14:845-852.
5. Dincer Y., Erzin Y., Himmetoglu S., et al. Oxidative DNA damage and antioxidant activity in patientsn with inflammatory bowel disease. Dig Dis Sci 2007, 52:1636-1641.
6. Naito Y., Takagi T., Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr 2007, 41:18-26.
7. Yoshida N., Murase H., Kunieda T., et al. Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits. Atherosclerosis 2002, 162:111-117.
8. Keshavarzian A., Morgan G., Sedghi S., et al. Role of reactive oxygen metabolites in experimental colitis. Gut 1990, 31:786-790.
9. Seril D.N., Liao J., Yang G.Y., et al. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003, 24:353-362.
10. Clark R.A., Epperson T.K., Valente A.J. Mechanisms of activation of NADPH oxidases. Jpn J Infect Dis 2004, 57:22-23.
11. Park D.W., Baek K., Kim J.R., et al. Resveratrol inhibits foam cell formation via NADPH oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1. Exp Mol Med 2009, 31:171-179.
12. Nauseef W.M. Biological roles for the NOX family NADPH oxidases. J Biol Chem 2008, 283:16961-16965.
13. Wendeburg L., de Oliveira A.C., Bhatia H.S., et al. Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells. J Neuroinflammation 2009, 14:6-26.
14. Zhu L.X., Jin Z.Y., Luo X. Study on the antioxidant activity of the resveratrol and piceid. Food Res Dev 2007, 28:22-25.
15. Singh U.P., Singh N.P., Singh B., et al. Resveratrol (trans-3,5,4'-trihydroxystilbene) induces SIRT1 and down-regulates NF-κB activation to abrogate DSS-induced colitis. J Pharmacol Exp Ther 2009, 11(332):829-839. [Epub ahead of print].
16. Sands B.E. Therapy of inflammatory bowel disease. Gastroenterology 2000, 118:68-82.
17. Katz J.A. Advances in the medical therapy of inflammatory bowel disease. Curr Opin Gastroenterol 2002, 18:435-440.
18. Aberra F.N., Lichtenstein G.R. Infliximab in ulcerative colitis. Gastroenterol Clin North Am 2006, 35:821-836.
19. Feagan B.G., Reinisch W., Rutgeerts P. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol 2007, 102:794-802.
20. Nishimoto N., Nakahara H., Yoshio-Hoshino N., et al. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthritis Rheum 2008, 58:1197-1200.
21. Ardizzone S., Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs 2005, 65:2253-2286.
22. Reddy J.G., Loftus E.V. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterol Clin North Am 2006, 35:837-855.
23. Murthy S.N., Cooper H.S., Shim H., et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporine. Dig Dis Sci 1993, 38:1722-1734.
24. Cooper H.S., Murthy S.N., Shah R.S., et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993, 69:238-249.
25. Murthy S., Murthy N.S., Coppola D., et al. The efficacy of BAYy 1015 in dextran sulfate model of mouse colitis. Inflamm Res 1997, 46:224-233.
26. Hirata I., Yasumoto S., Toshina K., et al. Evaluation of the effect of pyrrolidine dithiocarbamate in suppressing inflammation in mice with dextran sodium sulfate-induced colitis. World J Gastroenterol 2007, 13:1666-1671.
27. Kerem Z., Bilkis I., Flaishman M.A., et al. Antioxidant activity and inhibition of alpha-glucosidase by trans-resveratrol, piceid, and a novel trans-stilbene from the roots of Israeli Rumex bucephalophorus L. J Agric Food Chem 2006, 54:1243-1247.
28. Dal Sasso M., Culici M., Guffanti E.E., et al. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst. Pharmacology 2005, 74:127-134.
29. Hajj Hussein I.A., Tohme R., Barada K., et al. Inflammatory bowel disease in rats: bacterial and chemical interaction. World J Gastroenterol 2008, 14:4028-4039.
30. Camuesco D., Gálvez J., Nieto A., et al. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr 2005, 135:687-694.
31. Papadakis K.A., Targan S.R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000, 51:289-298.
32. Rogler G., Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998, 22:382-389.
33. Isaacs K.L., Sartor R.B., Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992, 103:1587-1595.
34. Blam M.E., Stein R.B., Lichtenstein G.R. Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease current and future perspectives. Am J Gastroenterol 2001, 96:1977-1997.
35. Chen H.J., Wu S.B., Chang C.M. Biological and dietary antioxidants protect against DNA nitration induced by reaction of hypochlorous acid with nitrite. Arch Biochem Biophys 2003, 415:109-116.
36. Karakilçik A.Z., Hayat A., Zerin M., et al. Effects of intraperitoneally injected selenium and vitamin E in rats anesthetized with halothane. J Trace Elem Med Biol 2003, 17:33-38.
37. Ademoglu E., Erbil Y., Tam B., et al. Do Vitamin E and selenium have beneficial effects on rinitrobenzenesulfonic acid-induced experimental colitis. Dig Dis Sci 2004, 49:102-108.
38. Kruidenier L., Kuiper I., Lamers C.B., et al. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003, 201:28-36.
39. Bai Y., Mao Q.Q., Qin J., et al. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci 2010, 101:488-493.
40. Choi H.Y., Chong S.A., Nam M.J. Resveratrol induces apoptosis in human SK-HEP-1 hepatic cancer cells. Cancer Genomics Proteomics 2009, 6:263-268.
41. Rubiolo J.A., Mithieux G., Vega F.V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 2008, 591:66-72.
42. Shang J., Chen L.L., Xiao F.X., et al. Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol Sin 2008, 29:698-706.